|
Mahamaya Lifesciences Ltd.
|
Income Statement
|
|
|
You can view the
Income Statement
for the last 5 years.
|
Market Cap. (Rs.)
|
280.39 Cr.
|
P/BV
|
4.74
|
Book Value (Rs.)
|
25.27
|
|
52 Week High/Low (Rs.)
|
122/111
|
FV/ML
|
10/1200
|
P/E(X)
|
21.66
|
|
Bookclosure
|
|
EPS (Rs.)
|
5.53
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 |
| | | | |
| | | | |
| INCOME | | | |
| Revenue From Operations [Net] | 264.15 | 161.57 | 137.08 |
| Total Operating Revenues | 264.15 | 161.57 | 137.08 |
| | | | |
| Other Income | 3.02 | 1.26 | 0.32 |
| Total Revenue | 267.17 | 162.83 | 137.40 |
| | | | |
| EXPENSES | | | |
| Cost Of Materials Consumed | 223.69 | 129.68 | 129.01 |
| Operating And Direct Expenses | 8.26 | 3.15 | 2.30 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -5.16 | 6.35 | -12.85 |
| Employee Benefit Expenses | 7.18 | 4.86 | 4.62 |
| Finance Costs | 6.83 | 5.90 | 2.85 |
| Depreciation And Amortisation Expenses | 1.77 | 1.48 | 1.27 |
| Other Expenses | 7.23 | 4.28 | 5.10 |
| Total Expenses | 249.81 | 155.71 | 132.30 |
| | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 17.36 | 7.12 | 5.10 |
| | | | |
| Profit/Loss Before Tax | 17.36 | 7.12 | 5.10 |
| | | | |
| Tax Expenses-Continued Operations | | | |
| Current Tax | 4.10 | 1.68 | 1.07 |
| Deferred Tax | 0.32 | 0.22 | 0.28 |
| Total Tax Expenses | 4.42 | 1.90 | 1.35 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 12.94 | 5.22 | 3.75 |
| | | | |
| Profit/Loss From Continuing Operations | 12.94 | 5.22 | 3.75 |
| | | | |
| Profit/Loss For The Period | 12.94 | 5.22 | 3.75 |
| Consolidated Profit/Loss After MI And Associates | 12.94 | 5.22 | 3.75 |
| | | | |
| OTHER INFORMATION | | | |
| | | | |
| EARNINGS PER SHARE | | | |
| Basic EPS (Rs.) | 7.60 | 3.26 | 2.34 |
| Diluted EPS (Rs.) | 7.60 | 3.26 | 2.34 |
